Indeed, our clinical data showed a strong positive correlation between the expression levels of USP21 and FOXD1 in GBM patients and demonstrated that elevated USP21 expression was negatively associated with GBM patient survival. The gene discussed is FOXD1; the disease is glioblastoma.